STAAR Surgical announced a public offering of 1,739,000 shares of common stock, according to a press release.
Proceeds from the offering, expected to be approximately $67,821,000, will be used to fund STAAR’s operations, including advancement of its implantable Collamer lens products and funding pipeline research and development activities, the release said.
Underwriters of the offering, which is subject to market conditions, will have a 30-day option to purchase up to 260,850 additional shares. The offering will close Aug. 10.
Uncategorized